September 18, 2023
Ausbil Investment Management Ltd Increases Stake in Exelon Co. (NASDAQ:EXC)
According to the recent disclosure filed with the U.S. Securities and Exchange Commission (SEC), Ausbil Investment Management Ltd bolstered its position in Exelon Co. during the second quarter of this year. The Australian investment management firm reported a 17.7% increase in its holdings of Exelon shares, purchasing an additional 15,107 shares and bringing its total ownership to 100,638 shares.
As per Ausbil Investment Management Ltd’s latest report, Exelon represents approximately 2.5% of their investment portfolio, ranking as their 13th largest holding. At the end of the second quarter, the value of Ausbil’s holdings in Exelon amounted to $4,100,000.
Exelon (NASDAQ:EXC) recently published its quarterly earnings data on August 2nd. The company surpassed analysts’ consensus estimates by reporting earnings per share (EPS) of $0.41 for the quarter, surpassing expectations by $0.01. Additionally, Exelon achieved a return on equity (ROE) of 9.20% and a net margin of 10.66%. The company generated $4.82 billion in revenue during this period compared to analysts’ predictions of $4.22 billion.
In comparison to the same quarter last year when Exelon posted EPS of $0.44, the business experienced a slight decrease in earnings per share for this quarter ($0.41). However, there was an overall annual increase of 13.7% in revenue.
Equities analysts anticipate that for the current fiscal year, Exelon Co.’s EPS will be around 2.35.
To learn more about Exelon and stay up to date with our research reports on EXC, please visit our website and access our latest findings and analysis.
Disclaimer: This article represents the views and opinions of Ausbil Investment Management Ltd as of September 18, 2023. The information provided herein is for informational purposes only and should not be relied upon as investment advice or recommendations regarding any particular securities. Investors must conduct their own research and analysis before making investment decisions.
[bs_slider_forecast ticker=”FNV”]
Institutional Investors Show Growing Interest in Exelon Co. as Stock Performance and Future Prospects Attract Attention
In the ever-evolving world of finance, it is crucial for investors and analysts to keep a close eye on the movements and decisions of major firms and institutional investors. In recent months, Exelon Co. has attracted significant attention as a number of large investors have bought and sold shares of the company.
One such investor is BlackRock Inc., which raised its position in Exelon by 4.3% during the first quarter of this year. With an additional purchase of 3,558,691 shares, BlackRock now owns a staggering 86,981,358 shares of the company’s stock, worth an estimated $3,643,649,000. State Street Corp also increased its stake in Exelon by 5.6% during the same period, acquiring an additional 3,271,744 shares valued at $2,597,969,000.
Bank of New York Mellon Corp followed suit by raising its holdings in Exelon by 1.1% during the third quarter last year. This brought their total ownership to 32,894,774 shares worth approximately $1,232,236,000. Geode Capital Management LLC joined the fray as well with a 1.4% increase in their stake during the first quarter this year. Their total ownership now stands at 18,515,401 shares worth $773,655000.
The interest in Exelon did not stop there; Deutsche Bank AG saw fit to boost its holdings by a whopping 41.4%, purchasing an additional 5,d224703 shares valued at $747673000 during the first quarter this year.
All these activities highlight how institutional investors have seized upon opportunities presented by Exelon Co.’s market performance and future prospects.
Institutional investors now own a staggering majority – approximately 81.38% – of Exelon’s stock as it stands today.
To further understand how these investments affect Exelon, it is important to examine the performance of its stock. On September 18, 2023, shares of EXC traded down $0.23 to reach a price of $41.42. This movement occurred while an exchange of 1,091,255 shares took place, deviating slightly from its average volume of 6,317,509 shares.
The company currently boasts a market capitalization of $41.22 billion and holds a favorable price-to-earnings ratio (P/E) of 19.65. Additionally, Exelon has a price-to-earnings-growth ratio (PEG) of 2.82 and a beta value of 0.62 – factors that analysts often consider when assessing investment opportunities.
When examining Exelon Co.’s financial health and liquidity position, one can observe that the company has a debt-to-equity ratio of 1.59 – reflecting how much the firm relies on borrowed funds compared to shareholder investments in its operations.
Furthermore, Exelon maintains strong liquidity ratios with quick and current ratios standing at 0.86 and 0.95 respectively as per the prevailing situation.
Investors remain curious about dividends when considering their potential returns from investing in any given company. In this regard, Exelon disclosed a quarterly dividend which was paid on September 8th to shareholders who were recorded as such on August 15th this year.
The dividend amounted to $0.36 per share and represents an annualized dividend payout ratio (DPR) of approximately 67.92%. This level provides some insight into how much profit the company distributes among its shareholders.
Given all these developments surrounding Exelon’s investment attractiveness and performance, various research reports have been published by reputable financial institutions analyzing the outlook for this energy giant.
Barclays assumed coverage and assigned an “overweight” rating alongside a $43 target price on August 23rd this year.
StockNews.com, on the other hand, took a bearish stance and initiated coverage with a “sell” rating for Exelon.
JPMorgan Chase & Co. maintained coverage of the company but decided to drop their target price from $50 to $46 in a research report dated June 7th.
In another research report from June 7th, The Goldman Sachs Group assumed coverage and also gave Exelon a “sell” rating accompanied by a $39 target price.
Finally, Morgan Stanley adjusted its price target from $47 to $44 and reiterated an “overweight” rating on August 23rd this year.
Overall, these reports highlight diverse opinions within the analyst community regarding Exelon’s future prospects. While there are two sell ratings, two hold ratings, and seven buy ratings for this stock based on data from Bloomberg.com, it is important to note that the consensus target price hovers around $44.10.
Investors and financial analysts alike will continue to track future developments surrounding Exelon as they strive to make informed decisions about this energy giant and its potential impact on portfolios.
